Cerebral malaria

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 4, 2000, Pages 433-441

  Newton, Charles R J C ^a   Hien, Tran Tinh ^b   White, Nicholas ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CHO QUAN HOSPITAL   (Viet Nam)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antimalarial drugs; Coma; Malaria; Parasitic disease

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLOROQUINE; CINCHONA ALKALOID; CLINDAMYCIN; CORTICOSTEROID; CYTOKINE; DEFEROXAMINE; DIAZEPAM; DOXYCYCLINE; FANSIDAR; MANNITOL; MEFLOQUINE; NITRIC OXIDE; PENTOXIFYLLINE; PHENOBARBITAL; QUINIDINE GLUCONATE; QUININE; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACIDOSIS; BLOOD DYSCRASIA; BRAIN EDEMA; BRAIN MALARIA; CLINICAL FEATURE; COMA; DOSE RESPONSE; DRUG ANTAGONISM; EXCHANGE BLOOD TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOGLYCEMIA; INFECTION; KIDNEY FAILURE; NEUROLOGICAL COMPLICATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; SEIZURE; TREATMENT OUTCOME; UNCONSCIOUSNESS;

EID: 0033798212     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.4.433     Document Type: Review

References (104)

1. Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 1998;79:1-53.
2. MacPherson GG, Warrell MJ, White NJ, et al. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 1985; 119:385-101.
3. Turner GDH, Morrison H, Jones M, et al. An immunohistiochemical study of the pathology of fatal malaria. Am J Pathol 1994;145:1057-69.
4. Brown H, Hien TT, Day N, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 1999;25:331-40.
5. Toro G, Roman G. Cerebral malaria. A disseminated vasculomyelinopathy. Arch Neurol 1978;35:271-5.
6. White NJ, Ho M. The pathophysiology of malaria. Adv Parasitol 1992;31:83-173.
7. Marsh K, Marsh VM, Brown J, et al. Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration. Exp Parasitol 1988;65:202-8.
8. Davis TME, Krishna S, Looareesuwan S, et al. Erythrocyte sequestration and anemia in severe falciparum malaria. J Clin Invest 1990;86:793-800.
9. Silamut K, White NJ. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg 1993;87:436-43.
10. Silamut K, Phu NH, Whitty C, et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 1999;155:395-410.
11. Riganti M, Pongponratn E, Tegoshi T, et al. Human cerebral malaria in Thailand: a clinico-pathological correlation. Immunol Lett 1990;25:199-205.
12. Kaul DK, Liu XD, Nagel RL, et al. Microvascular hemodynamics and in vivo evidence for the role of intercellular adhesion molecule-1 in the sequestration of infected red blood cells in a mouse model of lethal malaria. Am J Trop Med Hyg 1998;58:240-7.
13. Nash GB, Cooke BM, Marsh K, et al. Rheological analysis of the adhesive interactions of red blood cells parasitized by Plasmodium falciparum. Blood 1992;79:798-807.
14. Fujioka H, Aikawa M. The molecular basis of pathogenesis of cerebral malaria. Microb Pathog 1996;20:63-72.
15. Borst P, Bitter W, McCulloch R, et al. Antigenic variation in malaria: minireview. Cell 1995;82:1-4.
16. Berendt AR, Ferguson DJ, Gardner J, et al. Molecular mechanisms of sequestration in malaria. Parasitology 1994; 108(suppl):S19-28.
17. Berendt AR, Simmons DL, Tansey J, et al. Intracellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 1989;341:57-9.
18. Treutiger CJ, Hedlund I, Helmby H, et al. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg 1992;46:503-10.
19. Ockenhouse CF, Ho M, Tandon NN, et al. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 1991;164:163-9.
20. Ho M, Singh B, Looareesuwan S, et al. Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infect Immun 1991;59:873-8.
21. Newbold C, Warn P, Black G, et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 1997;57:389-98.
22. Fernandez RD, Craig AG, Kyes SA, et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 1997;6:1357-60.
23. Bellamy R, Kwiatkowski D, Hill AV. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans R Soc Trop Med Hyg 1998;92:312-16.
24. Rogerson SJ, Tembenu R, Dobano C, et al. Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. Am J Trop Med Hyg 1999;61:467-72.
25. Rowe A, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Nature 1997;63:2323-6.
26. Carlson J, Helmby H, Hill AV, et al. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 1990;336:1457-60.
27. Barragan A, Spillmann D, Kremsner PG, et al. Plasmodium falciparum: molecular background to strain-specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates. Exp Parasitol 1999;91:133-43.
28. Kaul DK, Roth EF, Nagel RL, et al. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 1991;78:812-19.
29. Rowe A, Obeiro J, Newbold CI, et al. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 1995;63:2323-6.
30. Cranston HA, Boylan CW, Carroll GL, et al. Plasmodium falciparum maturation abolishes physiologic red cell deformability. Science 1984;223:400-3.
31. Dondorp AM, Angus BJ, Hardeman MR, et al. Prognostic significance of reduced red blood cell deformability in severe falciparum malaria. Am J Trop Med Hyg 1997;57: 507-11.
32. Dondorp AM, Nyanoti M, Mithwani S, et al. Reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion. Am J Trop Med Hyg 2000;(in press).
33. Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989;320:1586-91.
34. Kwiatkowski D, Hill AV, Sambou I, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990;336:1201-4.
35. Clark IA, Rockett KA, Cowden WB. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992;340:894-6.
36. Day NP, Hien TT, Schollaardt T, et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis 1999;180:1288-97.
37. McGuire W, Hill AVS, Allsopp CEM, et al. Variation in the TNF-α promoter region associated with the susceptibility to cerebral malaria. Nature 1994;371:508-10.
38. McGuire W, Knight JC, Hill AV, et al. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999;179:287-90.
39. Kern P, Hemmer CJ, Gallati H, et al. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis 1992;166:930-4.
40. Karunaweera ND, Grau GE, Gamage P, et al. Dynamics of fever and serum TNF levels are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992;89:3200-3.
41. Kwiatkowski D, Molyneux ME, Stephens S, et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 1993;86:91-8.
42. van Hensbroek MB, Palmer A, Onyiorah E, et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 1996;174:1091-7.
43. Nussler AK, Eling W, Kremsner PG. Patients with Plasmodium falciparum malaria and Plasmodium vivax malaria show increased nitrate and nitrate plasma levels. J Infect Dis 1994;169:1418-19.
44. Al Yaman FM, Mokela D, Genton B, et al. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 1996;90:270-3.
45. al-Yaman FM, Genton B, Clark IA. The ratio of reactive nitrogen intermediates to tumour necrosis factor and clinical outcome of falciparum malaria disease. Trans R Soc Trop Med Hyg 1998;92:417-20.
46. Anstey NM, Weinberg JB, Wang Z, et al. Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expression in asymptomatic, malaria-exposed children. Am J Trop Med Hyg 1999;61:253-8.
47. Agbenyega T, Angus B, Bedu-Addo G, et al. Plasma nitrogen oxides and blood lactate concentration in Ghanaian children with malaria. Trans R Soc Trop Med Hyg 1997; 91:298-302.
48. Weiss G, Thuma PE, Biemba G, et al. Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J Infect Dis 1998;177:1064-8.
49. Dobbie MS, Crawley J, Waruiru C, et al. CSF studies in children with cerebral malaria: an excitoxic mechanism? Am J Trop Med Hyg 2000;(in press).
50. Taylor AM, Day NPJ, Sinh DXT, et al. Reactive nitrogen intermediates and outcome in severe adult malaria. Trans R Soc Trop Med Hyg 1998;92:170-5.
51. Warrell DA, Looareesuwan S, Warrell MJ, et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med 1982;306: 313-19.
52. Warrell DA, Molyneux ME, Beales PF. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;84(suppl 2):1-65.
53. Molyneux ME, Taylor TE, Wirima JJ, et al. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989; 71:441-59.
54. White NJ, Looareesuwan S. Cerebral malaria. In: Kennedy PGE, Johnson RI, eds. Infections of the nervous system. London: Butterworths, 1987:118-43.
55. White NJ, Warrell DA, Chanthavanich P, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983;309:61-6.
56. Taylor TE, Molyneux ME, Wirima JJ, et al. Blood glucose levels in Malawian children before and during the adminstration of intravenous quinine for severe falciparum malaria. N Engl J Med 1988;319:1040-7.
57. Looareesuwan S, Warrell DA, White NJ, et al. Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria. Am J Trop Med Hyg 1983;32:911-15.
58. Lewallen S, Harding SP, Ajewole J, et al. A review of the spectrum of clinical ocular fundus findings in P falciparum malaria in African children with a proposed classification and grading system. Trans R Soc Trop Med Hyg 1999;93: 619-22.
59. White NJ, Looareesuwan S, Phillips RE, et al. Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet 1988;ii:64-6.
60. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995;332:1399-404.
61. Waruiru cerebral malaria, Newton CR, Forster D, et al. Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg 1996;90:152-5.
62. Gordeuk V, Thuma P, Brittenham G, et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 1992;327:1473-7.
63. Newton CRJC, Chokwe T, Schellenberg JA, et al. Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg 1997;91:161-5.
64. Bondi FS. The incidence and outcome of neurological abnormalities in childhood cerebral malaria: a long term follow up of 62 surviviors. Trans R Soc Trop Med Hyg 1992; 86:17-19.
65. Crawley J, Smith S, Kirkham FJ, et al. Seizures and status epileticus in childhood cerebral malaria. Q J Med 1996;89: 591-7.
66. Crawley J, English M, Waruiru C, et al. Abnormal respiratory patterns in childhood cerebral malaria. Trans R Soc Trop Med Hyg 1998;92:305-8.
67. Brewster DR, Kwiatkowski D, White NJ. Neurological sequelae of cerebral malaria in children. Lancet 1990;336: 1039-43.
68. Walker O, Salako LA, Sowunmi A, et al. Prognostic risk factors and post mortem findings in cerebral malaria in children. Trans R Soc Trop Med Hyg 1992;86:491-3.
69. Waller D, Krishna S, Crawley J, et al. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis 1995;21:577-87.
70. Newton CR, Kirkham FJ, Winstanley PA, et al. Intracranial pressure in African children with cerebral malaria. Lancet 1991;337:573-6.
71. Waller D, Crawley J, Nosten F, et al. Intracranial pressure in childhood cerebral malaria. Trans R Soc Trop Med Hyg 1991;85:362-4.
72. Newton CR, Peshu N, Kendall B, et al. Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child 1994;70:281-7.
73. Newton CRJC, Marsh K, Peshu N, et al. Perturbations of cerebral hemodynamics in Kenyan children with cerebral malaria. Pediatr Neurol 1996;15:41-9.
74. Newton CR, Crawley J, Sowumni A, et al. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child 1997;76:219-26.
75. Clavier N, Rahimy C, Ayivi B, et al. No evidence for cerebral hypoperfusion during cerebral malaria. Crit Care Med 1999;628-32.
76. Holding PA, Stevenson J, Peshu N, et al. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg 1999;93:529-34.
77. Collomb H, Rey M, Dumas M, et al. Les hemiplegies au cours du paludisme aigu. Bulletin de la Societe D'Afrique Noire de longue Francaise 1967;7:791-5.
78. Omanga U, Ntihinyurwa M, Shako D, et al. Les hemiplegies au cours de l'acces pernicieux a plasmodium falciparum de l'enfant. Annals de Pediatrie 1983;30:294-6.
79. Wattanagoon Y, Srivilairit S, Looareesuwan S, et al. Convulsions in childhood malaria. Trans R Soc Trop Med Hyg 1994;88:426-8.
80. Luijckx GJ, De Krom MC, Takx-Kohlen BC. Does chloroquine cause seizures? Presentation of three new cases and a review of the literature. Seizure 1992;1:183-5.
81. English M, Waruiru C, Marsh K. Transfusion for respiratory distress in life-threatening childhood malaria. Am J Trop Med Hyg 1996;55:525-30.
82. Looareesuwan S, Wilairatana P, Krishna S, et al. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis 1995;21:300-9.
83. van der Torn M, Thuma PE, Mabeza GF, et al. Loading dose of quinine in African children with cerebral malaria. Trans R Soc Trop Med Hyg 1998;92:325-31.
84. White NJ, Looareesuwan S, Warrell DA, et al. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. Am J Med 1982;73:564-72.
85. Hien TT, White NJ. Qinghaosu. Lancet 1993;341:603-8.
86. White NJ. The treatment of malaria. N Engl J Med 1996;335:800-6.
87. van Hensbroek MB, Onyiorah E, Jaffar S, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996;335:69-75.
88. Hien TT, Day NP, Nguyen HP, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996;335:76-83.
89. McIntosh HM, Olliaro P. Treatment of severe malaria with artemisinin derivatives. A systematic review of randomised controlled trials. Med Trop (Mars) 1998;58:61-2.
90. Hien TT, Arnold K, Vinh H, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992;86:582-3.
91. Winstanley PA, Newton CR, Pasvol G, et al. Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects. Br J Clin Pharmacol 1992;33:149-54.
92. Crawley J, Waruiru C, Mithwani S, et al. Phenobarbitone halves the seizure frquency, but doubles the mortality in childhood cerebral malaria: results of a double blind, randomised controlled trial. Lancet 2000;26:355:701-6.
93. Hoffman SL, Rustama D, Punjabi NH, et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J Infect Dis 1988;158:325-31.
94. Looareesuwan S, Phillips RE, Karbwang J, et al. Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a renew of the literature. Q J Med 1990;227:471-81.
95. Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with continous infusions of quinidine gluconate and exchange transfusion. N Engl J Med 1989;321:65-70.
96. White NJ. Lumbar puncture in cerebral malaria. Lancet 1991;338:640-1.
97. Winstanley PA, Mberu EK, Watkins WM, et al. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. Trans R Soc Trop Med Hyg 1994;88:577-80.
98. McCaslin RI, Pikis A, Rodriquez WJ. Pediatric Plasmodium falciparum malaria: a ten-year experience from Washington DC. Pediatr Infect Dis J 1994;13:709-15.
99. Thuma PE, Mabeza GF, Biemba G, et al. Effect of iron chelation therapy on mortality in zambian children with cerebral malaria. Trans R Soc Trop Med Hyg 1998;92:214-18.
100. Di Perri G, Di Perri IG, Monteiro GB, et al. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis 1995;171:1317-22.
101. Davis TM, Supanaranond W, Pukrittayakamee S, et al. A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria. J Infect Dis 1990;161:1305-8.
102. White NJ, Looareesuwan S, Warrell DA, et al. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg 1983; 32:1-5.
103. Phillips RE, Warrell DA, White NJ, et al. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med 1985; 312:1273-8.
104. Murphy SA, Mberu E, Muhia D, et al. The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg 1997;91: 331-4.